Stock 399 INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Innovative Pharmaceutical Biotech Limited

Equities

399

BMG4783W1073

Industrial Machinery & Equipment

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.199 HKD 0.00% Intraday chart for Innovative Pharmaceutical Biotech Limited -0.50% -9.13%
2023 Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit MT
2023 Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 724.8 585.7 373.4 364.6 218.2 304.6
Enterprise Value (EV) 1 1,296 1,324 1,186 1,393 1,202 1,540
P/E ratio -3.14 x -2.25 x -1.77 x -1.78 x -4.15 x -1.24 x
Yield - - - - - -
Capitalization / Revenue 45.8 x 31.5 x 25.6 x 24 x 19.6 x 37.7 x
EV / Revenue 82 x 71.2 x 81.4 x 91.7 x 108 x 191 x
EV / EBITDA -53.1 x -49.3 x -36.7 x -64.6 x -49.2 x -80.8 x
EV / FCF -15.4 x -14.5 x -10.2 x -9.99 x -9.85 x -9.85 x
FCF Yield -6.49% -6.91% -9.76% -10% -10.1% -10.1%
Price to Book 3.69 x -7.81 x -0.96 x -0.61 x -0.4 x -0.38 x
Nbr of stocks (in thousands) 1,464,193 1,464,193 1,464,193 1,464,193 1,464,193 1,464,193
Reference price 2 0.4950 0.4000 0.2550 0.2490 0.1490 0.2080
Announcement Date 7/31/18 7/30/19 7/30/20 7/29/21 7/29/22 7/28/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 15.81 18.59 14.58 15.19 11.14 8.075
EBITDA 1 -24.4 -26.86 -32.3 -21.56 -24.4 -19.05
EBIT 1 -25.02 -26.93 -32.36 -21.6 -24.44 -20.93
Operating Margin -158.24% -144.88% -221.94% -142.19% -219.25% -259.21%
Earnings before Tax (EBT) 1 -231 -260.9 -222.5 -212.2 36.43 -254.7
Net income 1 -231 -260.3 -211.1 -204.9 45.8 -245.7
Net margin -1,461.31% -1,400.14% -1,447.99% -1,349.26% 410.97% -3,042.7%
EPS 2 -0.1578 -0.1778 -0.1442 -0.1400 -0.0359 -0.1678
Free Cash Flow 1 -84.16 -91.52 -115.7 -139.4 -122 -156.3
FCF margin -532.32% -492.32% -793.85% -917.57% -1,094.28% -1,934.99%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/31/18 7/30/19 7/30/20 7/29/21 7/29/22 7/28/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 572 738 813 1,028 984 1,235
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -23.42 x -27.49 x -25.16 x -47.69 x -40.31 x -64.84 x
Free Cash Flow 1 -84.2 -91.5 -116 -139 -122 -156
ROE (net income / shareholders' equity) -19.5% -28% -32.7% -45.8% 9.66% -95.1%
ROA (Net income/ Total Assets) -0.88% -1.02% -1.35% -0.96% -1.09% -0.94%
Assets 1 26,339 25,459 15,646 21,424 -4,196 26,099
Book Value Per Share 2 0.1300 -0.0500 -0.2700 -0.4100 -0.3800 -0.5400
Cash Flow per Share 2 0.0100 0.0100 0.0200 0.0100 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 7/31/18 7/30/19 7/30/20 7/29/21 7/29/22 7/28/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Industrial Machinery & Equipment Wholesale

1st Jan change Capi.
INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED Stock Innovative Pharmaceutical Biotech Limited
-9.13% 43.8M
W.W. GRAINGER, INC. Stock W.W. Grainger, Inc.
+12.14% 45.6B
FASTENAL COMPANY Stock Fastenal Company
+5.25% 39.03B
APPLIED INDUSTRIAL TECHNOLOGIES, INC. Stock Applied Industrial Technologies, Inc.
+4.75% 6.99B
DIPLOMA PLC Stock Diploma PLC
+0.95% 6.04B
MSC INDUSTRIAL DIRECT CO., INC. Stock MSC Industrial Direct Co., Inc.
-7.94% 5.25B
DNOW INC. Stock DNOW Inc.
+29.24% 1.59B
DISTRIBUTION SOLUTIONS GROUP, INC. Stock Distribution Solutions Group, Inc.
+4.63% 1.55B
BUFAB AB Stock Bufab AB
-12.73% 1.17B
TRUSCO NAKAYAMA CORPORATION Stock Trusco Nakayama Corporation
+3.80% 1.06B
Industrial Machinery & Equipment Wholesale
  1. Stock Market
  2. Equities
  3. 399 Stock
  4. Financials Innovative Pharmaceutical Biotech Limited